1. Abreu, S. L., 1983, Pharmacokinetics of rat fibroblast interferon, J. Pharmacol. Exp. Ther. 226: 197–200.
2. Ambler, L., and Hudson, A. M., 1984, Pharmacokinetics and metabolism of muramyl dipeptide and nor-muramyl dipeptide [3H-labelled] in the mouse. Int. J. Immunopharacol. 6:133–139.
3. Audhya, T. K., and Goldstein, G., 1985, Thymopentin: Stability considerations and potency by various routes of administration, Surv. Immunol. Res. 4 (Suppl. 1): 17–23.
4. Benard, P., Brunet, C., Cazin, M., Braun, J. P., Burgat-Sacaze, V., and Rico, A. G., 1980, Whole body distribution of 3H-levamisole in rats and mice, in: Mechanisms of Toxicity and Hazard Evaluation (B. Holmstedt, R. Lauwerys, M. Mercier, and M. Roberfiroid, eds.), Elsevier/North-Holland Biomedical Press, New York, pp. 529–532.
5. Billiau, A., 1983, The pharmacokinetics and toxicology of interferon, Soc. Gen. Microbiol. 35:255–276.